Infrared light therapy uses longer, invisible wavelengths (800-1200nm) to penetrate deeper into tissues. It primarily targets muscle recovery, joint pain, inflammation reduction, and improved circulation by stimulating cellular energy production.

While generally considered safe for the skin, direct, prolonged exposure of your eyes to the bright light from red light therapy devices, especially powerful panels, isn't recommended.

The sweet spot is typically 6-18 inches from your red light panel, but the exact distance depends heavily on your device's power output and your treatment goals. REDDOT LED panels provide specific guidelines based on our certified irradiance levels.

Begin with 5-15 minute daily sessions, adjusting based on your belt's irradiance levels (50-200 mW/cm²). Shorter, strategic treatments work better due to the biphasic dose response.

Unfortunately, without specific endorsements or public statements from Andrew Huberman, it's impossible to definitively say which red light panel he uses. However, it's likely that he prioritizes panels with specific wavelengths (660nm and 850nm) and sufficient irradiance, based on scientific literature. Many high-quality red light therapy panels on the market meet these criteria.

Focus on verified specs: clinically proven wavelengths, sufficient irradiance, essential safety certifications, appropriate size for your needs, and the manufacturer's reputation and transparency. These are the keys to an effective purchase.

Red light therapy (PBM) is not unsafe for cancer patients but not a cancer treatment. Used for supportive care; avoid active malignancy sites. Compliance and oncology clearance are critical.

Red light therapy (620–850 nm) boosts cellular ATP, aiding skin rejuvenation, hair regrowth, and reducing inflammation. FDA-cleared, low-risk, it suits clinics and homes but needs 8–12 weeks of consistent use. Caution is advised for certain medical conditions; device quality and proper dosing are critical.

Red light therapy may help manage rosacea symptoms by reducing inflammation and facial redness. The light can penetrate the skin and calm irritated tissues, potentially providing relief.

No, they aren't identical. While often grouped together and used in combination, red light and near-infrared (NIR) light are distinct parts of the light spectrum with different wavelengths and penetration depths. Think of them as related tools, not the same tool.

Red light therapy can reduce arthritis pain short term, especially in rheumatoid arthritis, by using 630–850 nm wavelengths to boost ATP and lower inflammatory cytokines. Effectiveness depends on correct dose and device output. Evidence is moderate and condition-specific, with stronger support for RA than OA. It works as an adjunct, not a cure, and long-term benefits remain uncertain.

Focus on key specs: clinically proven wavelengths (red 630-660nm, NIR 810-850nm), adequate power density (irradiance), essential safety certifications (like FDA/CE/ETL), device size/coverage, and the manufacturer's reputation. These factors determine effectiveness and safety.